文献速递关节外科

基于千例连续队列的活动平台单髁膝关节置换术循证适应证

Evidence-Based Indications for Mobile-Bearing Unicompartmental Knee Arthroplasty in a Consecutive Cohort of Thousand Knees.
PubMed 文献 · J Arthroplasty · 2016-12-27

研究基于1000例连续内侧活动平台单髁膝关节置换术的前瞻性队列,未应用既往报告的禁忌证,比较有或无禁忌证患者的功能结局与假体生存。68%的膝关节存在至少一项既往禁忌证,平均随访10年时两组美国膝关节协会客观评分(P=.05)与牛津膝关节评分(P=.08)无差异,有禁忌证组功能评分更优且差结局更少;15年假体生存无差异(P=.33)。结论认为既往禁忌证不应适用于活动平台单髁膝关节置换术。

要点

  • 1000例连续活动平台单髁膝关节置换术中68%(678膝)存在既往报告的禁忌证。
  • 平均随访10年,有禁忌证组美国膝关节协会功能评分、Tegner活动评分更优且差结局更少。
  • 15年假体生存两组无差异(P=.33),结论认为既往禁忌证不应适用于活动平台单髁。

核心结论

  • 该大样本病例系列提供证据表明,具有既往报告禁忌证的患者结局与无禁忌证者相当甚至更好。
  • 因此这些禁忌证不应适用于活动平台单髁膝关节置换术。

研究设计与样本

  • 前瞻性连续队列研究,纳入1000例内侧活动平台单髁膝关节置换术(818例患者),未应用既往报告的禁忌证。
  • 比较有或无既往报告禁忌证患者的功能结局与假体生存,平均随访10年(范围5-17年)。

主要发现

  • 1000例连续单髁膝关节置换术中68%(678膝)基于已发表禁忌证被认为存在禁忌证。
  • 平均随访10年,两组美国膝关节协会客观评分无差异(P=.05),牛津膝关节评分无差异(P=.08)。
  • 有禁忌证组差结局显著更少(P=.02),美国膝关节协会功能评分(P<.001)与Tegner活动评分(P<.001)显著更优。
  • 15年时假体生存无差异(P=.33)。
  • 年龄<60岁、体重≥180磅(82 kg)且高活动水平的年轻男性占3%,其10年美国膝关节协会功能评分(P<.001)、牛津膝关节评分(P=.01)、Tegner活动评分(P<.001)显著更优,10年客观评分(P=.54)与15年假体生存(P=.75)无差异。

关键数值与推荐

  • 既往推荐的禁忌证包括:年龄<60岁、体重≥180磅(82 kg)、从事重体力劳动、软骨钙化、髌股关节骨外露。
  • 有禁忌证组美国膝关节协会功能评分、Tegner活动评分显著更优(P<.001),差结局显著更少(P=.02)。
  • 15年假体生存两组无差异(P=.33)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The indications for unicompartmental knee arthroplasty remain controversial. Previously recommended contraindications include the following: age under 60 years, weight 180 lb (82 kg) or over, patients undertaking heavy labor, chondrocalcinosis, and exposed bone in the patellofemoral joint. This study explores whether these contraindications are valid in mobile-bearing unicompartmental knee arthroplasty. METHODS: Using a prospective series of 1000 consecutive medial unicompartmental knee arthroplasties in which the reported contraindications were not applied, the functional outcome and survival in patients with or without contraindications were compared. RESULTS: Of the 1000 consecutive unicompartmental knee arthroplasties (818 patients), 68% (678 knees) would be considered contraindicated based on published contraindications. At a mean follow-up of 10 years (5-17), there was no difference in American Knee Society (AKS) Objective Scores (P = .05) or Oxford Knee Score (P = .08) between groups. However, knees with contraindications had significantly (P = .02) fewer poor outcomes and significantly better AKS Functional Scores (P < .001) and Tegner Activity Scores (P < .001). At 15 years, no difference in implant survival (P = .33) was observed. The 3% of unicompartmental knee arthroplasties performed in young men (age <60) weighing 180 lb or over with high activity levels, who have been reported to have poor outcomes after fixed-bearing unicompartmental knee arthroplasty, had significantly better AKS Functional Scores (P < .001), Oxford Knee Score (P = .01), and Tegner Activity Score (P < .001) at 10 years. No difference in AKS Objective Scores (P = .54) at 10 years or implant survival at 15 years (P = .75) was seen. CONCLUSION: This large case series provides evidence that patients with the previously reported contraindications do as well as, or even better than, those without contraindications. Therefore these contraindications should not apply to mobile-bearing unicompartmental knee arthroplasty.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Hamilton TW, Pandit HG, Jenkins C, et al. Evidence-Based Indications for Mobile-Bearing Unicompartmental Knee Arthroplasty in a Consecutive Cohort of Thousand Knees. J Arthroplasty. 2016. PMID: 28131544. doi:10.1016/j.arth.2016.12.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。